Suppr超能文献

1例艾滋病患者的耐更昔洛韦巨细胞病毒(CMV)视网膜炎:血液各组分中CMV病毒载量及病毒突变的纵向分子分析

A case of ganciclovir-resistant cytomegalovirus (CMV) retinitis in a patient with AIDS: longitudinal molecular analysis of the CMV viral load and viral mutations in blood compartments.

作者信息

Boivin G, Gilbert C, Morissette M, Handfield J, Goyette N, Bergeron M G

机构信息

Infectious Disease Research Center, CHUL, Sainte-Foy, Québec, Canada.

出版信息

AIDS. 1997 Jun;11(7):867-73. doi: 10.1097/00002030-199707000-00005.

Abstract

OBJECTIVE

To study the temporal relationships between cytomegalovirus (CMV) viral load and specific UL97 mutations in polymorphonuclear leukocytes (PMNL) and plasma samples from a patient with AIDS who developed ganciclovir-resistant CMV retinitis.

METHODS

Sequential PMNL and plasma samples were analysed for determination of the CMV viral load using non-molecular methods and a quantitative polymerase chain reaction (PCR) assay. Screening of the same samples for the most common mutations conferring ganciclovir resistance was performed using nested PCR and restriction enzyme analysis.

RESULTS

At the time of progression of CMV retinitis (after 6 months of ganciclovir), a rapid increase in the CMV DNA load was found in both PMNL and plasma samples. This increase paralleled the emergence of a specific mutation (V594) in the same samples and recovery of ganciclovir-resistant blood isolates. In this patient, however, the only tests that substantially predicted the progression of CMV disease were the quantitative PCR assay using PMNL and to a lesser extent the pp65 antigenemia assay.

CONCLUSIONS

Quantitative evaluation of the CMV viral load in PMNL using sensitive assays such as PCR appears to be a promising approach for monitoring antiviral therapy in subjects with AIDS. In addition, common mutations conferring ganciclovir resistance can be detected directly in PMNL and plasma samples.

摘要

目的

研究一名患耐更昔洛韦巨细胞病毒视网膜炎的艾滋病患者多形核白细胞(PMNL)和血浆样本中巨细胞病毒(CMV)病毒载量与特定UL97突变之间的时间关系。

方法

使用非分子方法和定量聚合酶链反应(PCR)检测法对连续的PMNL和血浆样本进行分析,以测定CMV病毒载量。使用巢式PCR和限制性酶切分析对相同样本进行筛选,以检测赋予更昔洛韦抗性的最常见突变。

结果

在CMV视网膜炎进展时(更昔洛韦治疗6个月后),在PMNL和血浆样本中均发现CMV DNA载量迅速增加。这种增加与相同样本中特定突变(V594)的出现以及耐更昔洛韦血液分离株的恢复平行。然而,在该患者中,唯一能充分预测CMV疾病进展的检测方法是使用PMNL的定量PCR检测法,以及在较小程度上的pp65抗原血症检测法。

结论

使用如PCR等灵敏检测法对PMNL中的CMV病毒载量进行定量评估,似乎是监测艾滋病患者抗病毒治疗的一种有前景的方法。此外,可直接在PMNL和血浆样本中检测赋予更昔洛韦抗性的常见突变。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验